The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
    1. About this group
    2. Reviews
      1. Advice to reduce dietary salt for prevention of cardiovascular diseaseReview
      2. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertensionReview
      3. Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individualsReview
      4. Antiplatelet agents and anticoagulants for hypertensionReview
      5. Atorvastatin for lowering lipidsReview
      6. Beta-blockers for hypertensionReview
      7. Blood pressure lowering efficacy of alpha blockers for primary hypertensionReview
      8. Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertensionReview
      9. Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertensionReview
      10. Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertensionReview
      11. Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertensionReview
      12. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertensionReview
      13. Blood pressure lowering efficacy of diuretics as second-line therapy for primary hypertensionReview
      14. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertensionReview
      15. Blood pressure-lowering efficacy of loop diuretics for primary hypertensionReview
      16. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertensionReview
      17. Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertensionReview
      18. Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertensionReview
      19. Blood pressure lowering efficacy of potassium-sparing diuretics (that block the epithelial sodium channel) for primary hypertensionReview
      20. Blood pressure lowering efficacy of renin inhibitors for primary hypertensionReviewComment
      21. Blood pressure-lowering efficacy of reserpine for primary hypertensionReview
      22. Blood pressure targets for hypertension in people with diabetes mellitusReview
      23. Calcium channel blockers versus other classes of drugs for hypertensionReview
      24. Calcium supplementation for prevention of primary hypertensionReview
      25. Calcium supplementation for the management of primary hypertension in adultsReview
      26. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adultsReview
      27. Creatine and creatine analogues in hypertension and cardiovascular diseaseReview
      28. Dieting to reduce body weight for controlling hypertension in adultsReviewWithdrawn
      29. Effect of antihypertensive drugs on mortality, morbidity and blood pressure in blacksReviewWithdrawn
      30. Effect of cocoa on blood pressureReviewNew Search
      31. Effect of cyclosporine on blood pressureReview
      32. Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular eventReview
      33. Effect of longer-term modest salt reduction on blood pressureReview
      34. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglycerideReviewNew Search
      35. Eplerenone for hypertensionReview
      36. Evening versus morning dosing regimen drug therapy for hypertensionReview
      37. Fermented milk for hypertensionReview
      38. First-line beta-blockers versus other antihypertensive medications for chronic type B aortic dissectionReview
      39. First-line combination therapy versus first-line monotherapy for primary hypertensionReview
      40. First-line drugs for hypertensionReview
      41. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertensionReview
      42. Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patientsReview
      43. Hydralazine for essential hypertensionReview
      44. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settingsReview
      45. Interventions used to improve control of blood pressure in patients with hypertensionReview
      46. Long-term effects of weight-reducing diets in people with hypertensionReview
      47. Long-term effects of weight-reducing drugs in people with hypertensionReview
      48. Magnesium supplementation for the management of primary hypertension in adultsReview
      49. Methyldopa for primary hypertensionReview
      50. Pharmacological interventions for hypertension in childrenReview
      51. Pharmacological interventions for hypertensive emergenciesReview
      52. Pharmacotherapy for hypertension in the elderlyReview
      53. Pharmacotherapy for hypertension in women of different racesReview
      54. Pharmacotherapy for hyperuricemia in hypertensive patientsReviewNew Search
      55. Pharmacotherapy for mild hypertensionReview
      56. Potassium supplementation for the management of primary hypertension in adultsReview
      57. Relaxation therapies for the management of primary hypertension in adultsReview
      58. Renal denervation for resistant hypertensionReview
      59. Roselle for hypertension in adultsReview
      60. Rosuvastatin for lowering lipidsReview
      61. Spironolactone for hypertensionReview
      62. Thiazide diuretics and the risk of hip fractureReview
      63. Tianma Gouteng Yin Formula for treating primary hypertensionReview
      64. Time course for blood pressure lowering of dihydropyridine calcium channel blockersReview
      65. Treatment blood pressure targets for hypertensionReview
    3. Protocols
      1. Acupuncture for hypertensionProtocol
      2. Alcohol intake reduction for controlling hypertensionProtocol
      3. Allied health professional-led interventions for improving control of blood pressure in patients with hypertensionProtocol
      4. Angiotensin converting enzyme (ACE) gene polymorphism (ACEI/D) in hypertensive adults with ACE inhibitor-induced coughProtocol
      5. Angiotensin converting enzyme inhibitor induced angioedema in patients with primary hypertensionProtocol
      6. Blood pressure lowering effect of diuretics as second line therapy for primary hypertension in crossover trialsProtocol
      7. Blood pressure lowering efficacy of calcium-channel blockers as second-line therapy for primary hypertensionProtocol
      8. Blood pressure lowering efficacy of calcium channel blockers for primary hypertensionProtocol
      9. Blood pressure lowering efficacy of clonidine for primary hypertensionProtocol
      10. Blood pressure lowering efficacy of drugs inhibiting the renin-angiotensin system as second-line therapy for primary hypertensionProtocol
      11. Blood pressure targets for hypertension in older adultsProtocol
      12. Blood pressure targets for hypertension in patients with chronic renal diseaseProtocol
      13. Blood pressure targets for the treatment of patients with hypertension and cardiovascular diseaseProtocol
      14. Cerivastatin for lowering lipidsProtocol
      15. Cordyceps sinensis for hypertension in adultsProtocol
      16. Effect of adrenergic agonist oral decongestants on blood pressureProtocol
      17. Effect of amphetamines on blood pressureProtocol
      18. Effect of periodontal treatments on blood pressureProtocol
      19. First-line diuretics versus other classes of antihypertensive drugs for hypertensionProtocol
      20. Fish oil supplements for the prevention and treatment of hypertension in adultsProtocol
      21. Fluvastatin for lowering lipidsProtocol
      22. Interaction of calcium channel blockers and grapefruit juice in healthy adultsProtocol
      23. Interval training exercise for hypertensionProtocol
      24. Organisational interventions for improving control of blood pressure in individuals with hypertensionProtocol
      25. Pharmacotherapy for hypertension in adults with obstructive sleep apneaProtocol
      26. Pharmacotherapy for hypertension in non-elderly adultsProtocol
      27. Pharmacotherapy for hypertension-induced left ventricular hypertrophyProtocol
      28. Renin inhibitors versus angiotensin converting enzyme (ACE) inhibitors for primary hypertensionProtocol
      29. Renin inhibitors versus angiotensin receptor blockers for primary hypertensionProtocol
      30. Resistance exercise training for hypertensionProtocol
      31. Self-monitoring for improving control of blood pressure in patients with hypertensionProtocol
      32. Statins for preventing major vascular events in people with hypertensionProtocol
      33. Tai Chi for hypertensionProtocol
      34. Time course for blood pressure lowering of alpha blockersProtocol
      35. Time course for blood pressure lowering of angiotensin-converting-enzyme inhibitorsProtocol
      36. Time course for blood pressure lowering of angiotensin receptor blockersProtocolNew
      37. Time course for blood pressure lowering of beta blockers with partial agonist activityProtocol
      38. Time course for blood pressure lowering of beta one selective blockersProtocol
      39. Time course for blood pressure lowering of dual alpha and beta blockersProtocol
      40. Time course for blood pressure lowering of thiazidesProtocol
      41. Walking for hypertensionProtocol
      42. Withdrawal of antihypertensive drugs in older peopleProtocol
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH